8x8 Issued New Communications Patent By U.S. Patent And Trademark Office

8x8, Inc. (NASDAQ: EGHT), provider of innovative cloud communications solutions, today announced that it has been awarded a new patent related to its communications technologies. On March 19, 2013, the U.S. Patent and Trademark Office issued United States Patent number 8,401,003 entitled “Method and System for Updating Physical Location Information.”

This patent relates to a method and system for updating physical location data associated with a Voice over Internet Protocol (“VoIP”) endpoint. The invention utilizes address and state information available to the VoIP endpoint device to facilitate an update of the physical location data associated with a VoIP host server via the VoIP endpoint device.

Since its establishment in 1987, 8x8 has been awarded eighty-six (86) United States patents covering a variety of voice and video communications, signaling, processing and storage technologies. 8x8’s Chairman and Chief Executive Officer, Bryan Martin, is a named inventor on the newly issued patent.

About 8x8, Inc.

8x8, Inc. (NASDAQ: EGHT) empowers business conversations for more than 30,000 small and medium-sized businesses with cloud communications services that include hosted PBX telephony, unified communications, contact center and video conferencing solutions. The company has been delivering business communications services since 2004 and has garnered a reputation for technical excellence and outstanding reliability. In 2012, 8x8 was named a market “leader” in Gartner’s Magic Quadrant for Unified Communications as a Service (UCaaS) in North America and recognized as the No. 1 Provider of Hosted IP Telephony by Frost & Sullivan. For additional information, visit  www.8x8.com, or connect with 8x8 on Facebook and Twitter.

Copyright Business Wire 2010

If you liked this article you might like

My Market Scans are Unimpressive

8x8 (EGHT) Stock Rises on Q1 Earnings Beat

8x8 (EGHT): Today's Weak On High Volume Stock

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

'Mad Money' Lightning Round: Buy, Buy, Buy Seres Therapeutics